Tumor therapy by targeting extracellular hydroxyapatite using novel drugs: A paradigm shift.
Tantawy MN, McIntyre JO, Yull F, Calcutt MW, Koktysh DS, Wilson AJ, Zu Z, Nyman J, Rhoades J, Peterson TE, Colvin D, McCawley LJ, Rook JM, Fingleton B, Crispens MA, Alvarez RD, Gore JC.
Tantawy MN, et al.
Cancer Med. 2024 Feb;13(3):e6812. doi: 10.1002/cam4.6812. Epub 2024 Jan 18.
Cancer Med. 2024.
PMID: 38239047
Free PMC article.